Regulatory Updates
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 1–12 of 380 articles
Quick answer
NovaPharmaNews Regulatory Updates hub for FDA covers 380 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.

Monopar Starts Rolling NDA for ALXN1840 Wilson
FDA · Rare Diseases · 3 min
Sarah Chen
FDA Accepts Daraxonrasib NDA for Pancreatic Cancer
FDA · Oncology · 3 min
Sarah Chen
Commissioner National Priority Voucher CNPV Pilot
FDA · Regulatory Policy · 3 min
Sarah Chen
FDA Finalizes Guidance on Clinical Trial Design
FDA · Psychiatry · 3 min
Sarah Chen
FDA Activity Round Up July 2026
FDA · 3 min
Sarah Chen
Drug Repurposing Stakeholders Say FDA Should Act
FDA · 3 min
Sarah Chen
Compounded GLP-1s Why doctors worry and FDA acts
FDA · Metabolic Disorders · 3 min
Sarah ChenFDA approves OTC Rextovy, broadening naloxone access for opioid overdose
FDA · opioid overdose · 6 min
Sarah ChenLilly buys 4E in non-opioid pain push: what investors should watch
FDA · moderate to severe acute pain · 6 min
Sarah ChenLilly’s early JAK data raises myelofibrosis competition question
FDA · myelofibrosis · 6 min
Sarah ChenFDA authorizes emergency pet treatment for New World screwworm
FDA · New World screwworm · 4 min
Michael RodriguezFDA guidance on sharing potential NDA patent information: what changes now
FDA · 4 min
Sarah ChenFrequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.
Explore intelligence